PCN192 COST-EFFECTIVENESS OF NIVOLUMAB FOR THE ADJUVANT TREATMENT OF PATIENTS WITH MELANOMA WITH INVOLVEMENT OF LYMPH NODES OR METASTATIC DISEASE WHO HAVE UNDERGONE COMPLETE RESECTION IN GREECE

Category Systematic review
JournalValue in Health
Year 2019
This article has no abstract
Epistemonikos ID: 0937c398a04e50c50c7c669dcb3fd20319480526
First added on: Feb 11, 2025